Baraliakos X, et al. Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial. ACR 2018, abstract L13.
Lage glucosewaarden bij adalimumab
okt 2022 | Arthritis psoriatica, Artritis, Dialyse, IBD, Psoriasis, RA, Spondyloartritis